Literature DB >> 19015654

The effects of hormone replacement therapy on renal function.

Sharon Silbiger1.   

Abstract

This Practice Point commentary discusses a study by Ahmed et al. that evaluated the effects of hormone replacement therapy (conjugated estrogen alone, progestin alone or a combination of progestin and conjugated estrogen) on renal function in elderly community-dwelling postmenopausal women. The authors found that oral estrogen therapy in this population was associated with accelerated decline in kidney function over a 2-year period. In addition, the cumulative amount of estrogen intake was dose-dependently associated with the rate of renal functional decline. This commentary highlights the human and experimental evidence suggesting that endogenous and exogenous estrogen affect renal function, and discusses the possible beneficial or detrimental effects of hormone supplementation on kidney function.

Entities:  

Year:  2008        PMID: 19015654     DOI: 10.1038/ncpneph0993

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  7 in total

1.  Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

Authors:  Sofia B Ahmed; Peter Hovind; Hans-Henrik Parving; Peter Rossing; Deborah A Price; Lori M Laffel; M Cecilia Lansang; Radomir Stevanovic; Naomi D L Fisher; Norman K Hollenberg
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

2.  The relationship between albuminuria and hormone therapy in postmenopausal women.

Authors:  Mamta Agarwal; Vani Selvan; Barry I Freedman; Yongmei Liu; Lynne E Wagenknecht
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

3.  Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

Authors:  B Szekacs; Z Vajo; S Varbiro; R Kakucs; L Vaslaki; N Acs; I Mucsi; E A Brinton
Journal:  BJOG       Date:  2000-08       Impact factor: 6.531

4.  Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

Authors:  T B Monster; W M Janssen; P E de Jong; L T de Jong-van den Berg
Journal:  Arch Intern Med       Date:  2001-09-10

Review 5.  The role of gender in the progression of renal disease.

Authors:  Sharon R Silbiger; Joel Neugarten
Journal:  Adv Ren Replace Ther       Date:  2003-01

6.  Oral estrogen therapy in postmenopausal women is associated with loss of kidney function.

Authors:  Sofia B Ahmed; Bruce F Culleton; Marcello Tonelli; Scott W Klarenbach; Jennifer M Macrae; Jianguo Zhang; Brenda R Hemmelgarn
Journal:  Kidney Int       Date:  2008-05-21       Impact factor: 10.612

Review 7.  Gender and human chronic renal disease.

Authors:  Sharon Silbiger; Joel Neugarten
Journal:  Gend Med       Date:  2008
  7 in total
  3 in total

1.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

2.  Premature and early menopause among US women with or at risk for HIV.

Authors:  Brooke W Bullington; Andrew Edmonds; Catalina Ramirez; Lisa Rahangdale; Genevieve Neal-Perry; Deborah Konkle-Parker; Deborah Jones Weiss; Caitlin Moran; Elizabeth Topper Golub; Helen Cejtin; Dominika Seidman; Seble Kassaye; Tracey E Wilson; Anjali Sharma; Adaora A Adimora; Andrea K Knittel
Journal:  Menopause       Date:  2022-06-01       Impact factor: 3.310

3.  Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome.

Authors:  Annalisa Perna; Barbara Ruggiero; Manuel Alfredo Podestà; Luca Perico; Silvia Orisio; Hanna Debiec; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.